0001104659-21-046743.txt : 20210405
0001104659-21-046743.hdr.sgml : 20210405
20210405213015
ACCESSION NUMBER: 0001104659-21-046743
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210401
FILED AS OF DATE: 20210405
DATE AS OF CHANGE: 20210405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dugel Pravin
CENTRAL INDEX KEY: 0001700917
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 21807919
MAIL ADDRESS:
STREET 1: C/O AERPIO PHARMACEUTICALS, INC.
STREET 2: 9987 CARVER ROAD
CITY: CINCINNATI
STATE: OH
ZIP: 45242
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IVERIC bio, Inc.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208185347
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 PENN PLAZA
STREET 2: SUITE 2372
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 212-845-8200
MAIL ADDRESS:
STREET 1: 5 PENN PLAZA
STREET 2: SUITE 2372
CITY: NEW YORK
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: Ophthotech Corp.
DATE OF NAME CHANGE: 20070828
4
1
tm2112227-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-04-01
0
0001410939
IVERIC bio, Inc.
ISEE
0001700917
Dugel Pravin
C/O IVERIC BIO, INC.
FIVE PENN PLAZA, SUITE 2372
NEW YORK, NEW YORK
10001
0
1
0
0
EVP, Chief Strategy & Business
Common Stock
2021-04-01
4
M
0
50000
A
50000
D
Common Stock
2021-04-01
4
M
0
20000
A
70000
D
Common Stock
2021-04-05
4
S
0
28301
6.34
D
41699
D
Restricted Stock Units
2021-04-01
4
M
0
50000
0
D
Common Stock
50000
150000
D
Restricted Stock Units
2021-04-01
4
M
0
20000
0
D
Common Stock
20000
0
D
Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of restricted stock units on April 1, 2021.
The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $6.28 to $6.47 on April 5, 2021 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
On April 1, 2020, the Reporting Person was granted 200,000 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan.
On April 1, 2020, the Reporting Person was granted 20,000 restricted stock units, which vested with respect to 100% of the shares subject to the award on the first anniversary of the grant date on April 1, 2021.
/s/ Todd Anderman, as Attorney-in-Fact for Pravin
2021-04-05